LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Liabilities, Financing Arrangements
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Deferred Tax Liabilities, Financing Arrangements of $0 as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesFinancingArrangements · last filed 2020-02-27
- 2019-12-31: Deferred Tax Liabilities, Financing Arrangements $0.00.
- 2018-12-31: Deferred Tax Liabilities, Financing Arrangements $2.90M.
- 2017-12-31: Deferred Tax Liabilities, Financing Arrangements $737.00K.
- 2016-12-31: Deferred Tax Liabilities, Financing Arrangements $1.20M.
| Period end | Deferred Tax Liabilities, Financing Arrangements |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2018-12-31 | $2.90M 10-K · filed 2020-02-27 |
| 2017-12-31 | $737.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $1.20M 10-K · filed 2018-03-01 |
| 2015-12-31 | $1.84M 10-K · filed 2017-02-28 |
| 2014-12-31 | $1.44M 10-K · filed 2016-11-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 |